Pharma Stocks Get Hit As Biden Weighs In… Plus Tesla’s Delivery Beat 7/2/24

Eli Lilly and Novo Nordisk getting hit as President Biden says they’re “ripping off Americans”. The rising costs of weight loss drugs, and the political impact on the pharma space. Plus Tesla charges higher. The EV maker reporting strong delivery numbers, extending the stock’s recent win streak. But could shares be nearing a key resistance level? How the technicals are looking in this name. Fast Money Disclaimer

Shares of Apple nearing record highs as reports of a China iPhone rebound helps fuel investor optimism. But not everyone’s believing the reversal. What analysts are saying about the recovery in the mainland. Plus Hedging into the second half. After a strong first half, here’s how you should position for the rest of the year. Fast Money Disclaimer

Shares of Nike plummeting after reporting results, as the sneaker giant warns of a major sales slowdown. But one of our traders is using the plunge as an opportunity. Plus the fast food price wars are heating up, but could the payment stocks be getting burned in the process. How that space is being impacted. Fast Money Disclaimer

Nike swooshing lower after reporting a revenues miss. The details out of the company’s conference call, and how you should play the retailer. Plus Presidential impact. A look at the economic records under President Biden and Former Presiden Trump, as the two go head-to-head in tonight’s presidential debate. Fast Money Disclaimer

Nvidia leading a semi selloff, as the company’s shareholder meeting sheds light on growing competition. What the moves mean for the chip trade. Plus Bank stocks in focus after the Fed’s stress test results. Why one investment firm’s CEO says the group is in great shape. Fast Money Disclaimer

Shares of FedEx soaring after its latest earnings report. The numbers behind the move and all the details out of the conference call. Plus, all things housing taking a hit, as economists forecast a “stuck” market for the next few years. And it’s not just the builders feeling the pain. The related names seeing some losses.  Fast Money Disclaimer 

Nvidia notching another day of losses, but the broader markets aren’t taking it too hard. How investors are handling the semi slide. Plus A big jump for one biopharma stock as Alnylam delivers promising new heart drug results. What the CEO had to say about the data, and the impact it could have on the space. Fast Money Disclaimer

Has the fever broken for the high momentum stocks? Nvidia running out of steam this week, as some other high fliers also pull back. Is this just a bump in the road or the beginning of a summer slowdown? Plus Sarepta’s big surge. The biotech company getting expanded approval from the FDA for its muscular dystrophy drug. What the CEO says is next for the company. Fast Money Disclaimer 

Some of this year’s red hot stocks have seemed to hit a wall. Nvidia, Chipotle, Netflix… all taking a leg lower in today’s session. Is the pullback temporary? Or could there be more downside ahead. Plus Gilead’s big boost. Shares jumping after the biotech company’s latest trial results. What the data could mean in the fight against HIV. Fast Money Disclaimer 

There’s a new biggest bull on Wall Street, as Evercore’s Julian Emanuel ups his year-end price target on the S&P by 25% to a whopping 6,000/ What’s going to drive those returns and how should you play the market? Plus Industrials have been struggling so far in 2024, but one top technician says these names are about to witness a turnaround. We go off the charts to get the details. Fast Money Disclaimer